Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

Market Cap	6.43B
Revenue (ttm)	3.43B
Net Income (ttm)	372.83M
Shares Out	153.40M
EPS (ttm)	2.46
PE Ratio	17.04
Forward PE	n/a
Dividend	0.90 (2.15%)
Ex-Dividend Date	Apr 30, 2025

Volume	1,161,275
Average Volume	2,487,348
Open	42.16
Previous Close	41.93
Day's Range	41.83 - 42.30
52-Week Range	39.75 - 66.80
Beta	0.73
RSI	37.75
Earnings Date	Aug 15, 2025

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,497
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600976

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.